Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
2,678,889
-
Shares change
-
-109,332
-
Total reported value, excl. options
-
$222,557,936
-
Value change
-
-$9,708,244
-
Number of buys
-
42
-
Number of sells
-
-43
-
Price
-
$83.08
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2018
98 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q4 2018.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,678,889 shares
of 3,203,885 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include FMR LLC (477,007 shares), PRICE T ROWE ASSOCIATES INC /MD/ (292,592 shares), RENAISSANCE TECHNOLOGIES LLC (239,214 shares), BlackRock Inc. (189,228 shares), LAZARD ASSET MANAGEMENT LLC (187,362 shares), Vanguard Group Inc (180,445 shares), DIMENSIONAL FUND ADVISORS LP (175,614 shares), STATE STREET CORP (95,617 shares), LOOMIS SAYLES & CO L P (63,251 shares), and THOMSON HORSTMANN & BRYANT INC (58,533 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.